Skip links

Pharma Strategist’s Blog: Developing a Portfolio Strategy

Approaches to portfolio strategy have become more holistic across the healthcare industry, but what are the benefits for business?

Authored by Maxine Smith, Managing Director, and Strategic Consultant Laura Fontana Sabatini, Uptake Strategies for the PME Pharma Strategists’ Blog

In this article for Pharma Market Europe, Managing Director, Maxine, and Senior Consultant, Laura, share the benefits of portfolio strategy for business. Maxine explains how developing a portfolio strategy can sometimes feel like you have just been handed a bag of repelling magnets and asked to fit them all together.

Maxine and Laura suggest looking at the vision of what the portfolio strategy could be and building it collaboratively. To be successful in developing and implementing a portfolio strategy, we need to consider our team, our company, customers and healthcare systems, patients, carers, and society.

Once this longer-term view is mapped out, the team can explore what will stop or slow this progress, what will need to change, what will enable change, and so on, as the plan for how to transition becomes clearer.

Even within a wider portfolio or disease strategy, it is always important to know the component parts and what is needed to maximise all parts that make up the whole.

However, sometimes by working to connect the brand ‘magnets’, together we can build extraordinary structures that help us realise the internal and external benefits to be gained.

→ Read the full article here